Cromwell Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Cromwell Holdings's VRTX Position: Q2 2026 in Review
Cromwell Holdings increased its Vertex Pharmaceuticals (VRTX) stake by 0.15% in Q2 2026, buying an estimated $443 and bringing the position to 664 shares worth $330K. The position accounts for 0.15% of the portfolio, ranked #117.
Cromwell Holdings first reported a position in VRTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $386K in Q3 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Cromwell Holdings held 664 shares of Vertex Pharmaceuticals worth $330K as of Q2 2026.
- Cromwell Holdings bought 1 Vertex Pharmaceuticals share in Q2 2026, an estimated $443.
- Vertex Pharmaceuticals made up 0.15% of Cromwell Holdings's portfolio in Q2 2026, its #117 holding.
- Cromwell Holdings first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
- Cromwell Holdings's Vertex Pharmaceuticals position peaked at $386K in Q3 2024.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.